NASP’s Comments on HHS’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; Request for Information

Feb 16, 2017 · Advocacy

The National Association of Specialty Pharmacy (NASP) represents the entire spectrum of the specialty pharmacy industry from the nation’s leading independent specialty pharmacies and practicing pharmacists to small and mid-size pharmacy benefit managers (PBMs), pharmaceutical and biotechnology manufacturers of specialty drugs; group purchasing organizations; wholesalers and distributors; integrated delivery systems and health plans; and technology and data management companies. NASP has submitted the following comments related to the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs and Request for Information.

Please click here to review our comments in their entirety